Wearable technologies have the power to open doors for long-run continuous mensuration and of observation patients whose chronic condition includes the danger of unforeseen acute events. 

Hilaris Conferences on Cardiology and Cardiac Surgery 2020 provide the chance to discuss thereon quite innovations in cardiology just like the inclusion of the soft robotic sleeve that may probably be used for short-run cardiac rehabilitation additionally to long-run medical care.

Today, many procedures that were once very invasive are presently being performed via minimally invasive techniques, with the extra advantage of robotic preciseness and radiation protection. The innovations of cardiology are serving in higher and furthermore as minimizing the danger concerned.

The advancements in Interventional Cardiology and therefore the advantages with those innovations like fewer vascular complications, reduced use of contrast agents and reduced hemostasis are amongst the topics about to be mentioned within the conference.

Hilaris Conferences are conceptualized to provide accomplished vision into the major concepts of cardiology. The conference on Cardiology and Cardiac Surgery intensify on topics like cardiac surgery, cardiovascular diseases, valvular heart disease, arrhythmia and pacing, acute coronary syndromes, cardiac imaging, aneurysm along with the prevention and care need to be taken while undergoing strategic treatments.

Hilaris Conference on Cardiology and Cardiac Surgery in 2020 you can learn from the most effective of the most effective. There are several misconceptions and previous pointers that get challenged by our leading researchers and practitioners.

United States has its prominence in the field of cardiology from the past 20 years with major innovations focused on various cardiology departments like Ischemic heart disease, Acute coronary syndromes, and interventional cardiology, Valvular heart diseases, hypertension, and heart failure, Arrhythmia, and sudden death prevention, Myocardial and pericardial diseases, and also in rare cardiovascular disorders Italian Federation of cardiology through its educational activities and grants continually has been supporting the new generation physicians and scientists who can contribute, as within the distant and up to date past, to create cardiology history.

Who Should Attend:
Hilaris Conferences welcomes all the great scientists, academicians, young researchers, Business delegates and students from all over the world to attend the conference on Cardiology and Cardiac Surgery.

Target Audience:
From Academic Field-



Cardiology Students

     Professors of medical universities

Cardiac Surgeons

Medical Peers

Cardiac Practitioners



Academic Scientists

Cardiac Diagnostics Associations and Societies

Postdoctoral Fellows and Trainees



Health care analysts

​​​​​​From Business/Industry Field-

Business Entrepreneurs

Pharmaceutical Corporations

Medical Devices Corporations

Industry Professionals


Supporting Journals


Marketing Executives

Medical Representatives

The Cardio vascular devices market is projected to reach USD 14.4 billion by 2024 from USD 10.3 billion in 2019 at a CAGR of 6.8.market growth can be attributed to the rapid growth in the geriatric population and the associated increase in the prevalence of peripheral vascular disease approval of new and advanced products and the growing preference for minimally invasive surgeries the America is going to register the highest growth rate in the peripheral vascular devices market during the forecast period the global diagnostic catheters market is expected to reach USD 4302.3 million by 2021, at a CAGR of 7.3 from 2016 the America holds significant growth opportunities’ for market players. 

The American interventional cardiology market is currently valued at nearly $1.4 billion. across most of the market, certain devices, such as FFR guidewires and OCT catheters, are expected to exhibit strong growth over the next several years. The increasing incidence of cardiovascular diseases and the growing geriatric population are the most significant factors driving the growth of the global cardiovascular devices market.
According to the American Heart Network, every year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Furthermore, other factors such as the rapid technological advances, increasing awareness of the population, and high preference of minimally invasive procedures are also supplementing the market growth.

Top 10 Medicine Universities Across the World:

  • Harvard University, U.S.A
  • University of Oxford, England
  • University of Cambridge, Europe
  • Stanford University, San Francisco 
  • Johns Hopkins University, USA
  • Karolinska Institute, Sweden
  • University of California Los Angeles (UCLA)
  • Yale University, U.S.A
  • Massachusetts Institute of Technology (MIT), Cambridge.
  • University College London (UCL)

Top 10 Cardiology Hospitals Across the World:

  • Cleveland Clinic (Cleveland, OH)
  • Mayo Clinic (Rochester, MN)
  • Cedars-Sinai Medical Center (Los Angeles, CA)
  • New York-Presbyterian Hospital-Columbia and Cornell (New York, NY)
  • Massachusetts General Hospital (Boston, MA)
  • Hospitals of the University of Pennsylvania-Penn Presbyterian (Philadelphia, PA) 
  • Northwestern Memorial Hospital (Chicago, IL)
  • Brigham and Women’s Hospital (Boston, MA)
  • University of Michigan Hospitals-Michigan Medicine (Ann Arbor, MI)
  • Mount Sinai Hospital (New York, NY)

Top Pharma Companies for Cardiology Drug In World:

  • Bayer (Leverkusen)
  • Sanofi (Paris)
  • Bristol-Myers Squibb (New York)
  • Johnson and Johnson (New Jersey)
  • Pfizer (New York)
  • Novartis (Switzerland)
  • AstraZeneca (Cambridge)
  • Daiichi Sankyo (Japan)
  • Gilead (California)
  • United Therapeutics (Maryland)

Join Our Newsletter